Skip to main content
OpenTrials
Completed

NCT Number: NCT06003933

Inter-semispinal Plane Block and Cervical Spine Surgery

The inter-semispinal plane (ISP) block is a novel ultrasound-guided technique that involves local anesthetic injection into the fascial plane between the semispinalis cervicis and semispinalis capitis muscles with subsequent block of the dorsal rami of the cervical spinal nerves and hence can get adequate postoperative analgesia.

The authors hypothesized that ISP block can reduce the postoperative analgesic consumption in patients undergoing posterior cervical spine surgeries.

The aim of this study is to evaluate the analgesic efficacy of ISP block in patients undergoing posterior cervical spine surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fayoum University Hospital

Al Fayyum, Faiyum Governorate, 63514, Egypt

About this study

This study will be performed in the in the Fayoum University hospital after the local Institutional Ethics Committee and local institutional review board approval. The study design will be double-blind randomized controlled study . A detailed informed consent will be signed by the eligible patients before recruitment and randomization.

Patients were randomly allocated into two groups using computer generated sequence and concealed in sealed opaque envelopes.

Control group (C): patients received general anesthesia only. Inter-semispinal plane (ISP) block group: patients received bilateral ultrasound guided ISP block at the level of C5.

All patients will be assessed Preoperative VAS score then premedicated orally with midazolam 0.5 mg/kg 30 min prior to surgery. All patients were monitored by 5 lead ECG, pulse oximetry, non-invasive blood pressure and capnography and an intravenous (IV) access will be established.

The technique of general anesthesia will be standardized for all patients. General anesthesia will be induced by intravenous (IV) 2 mg/kg propofol and 1 μg/kg fentanyl induction. After IV atracurium 0.5 mg/kg, orotracheal intubation was performed. Anesthesia will be maintained with isoflurane (1.2%-1.5%) in oxygen-air mixture (50%-50%). Muscle relaxation will be maintained during the procedure with atracurium in increments.

After induction of general anesthesia, ISP blocks will be performed in the allocated group with the patient in the prone position. In both groups, the treating anesthesiologist left the operating room while another anesthesiologist experienced in ultrasound guided nerve block techniques; with no subsequent role in the study; either performed the ISP blocks in the ISP group, or just prepared the skin and scanned the site of the block using the ultrasound probe in the control group. Fifteen minutes will be awaited in all patients before the surgical procedure was allowed to start.

fentanyl 0.5 μg/kg IV will be administered in case of inadequate analgesia as indicated by >20% increase in heart rate or mean arterial blood pressure. Total intraoperative fentanyl consumption will be recorded.

All anesthetics will be discontinued at the end of the surgical procedure. Extubation will be performed when spontaneous breathing was adequate and following prompt reversal using 0.05 mg/kg of neostigmine and 0.02 mg/kg of atropine. At the end of surgery, paracetamol 1 g will be administered IV to be repeated every 6 h postoperatively. Patients will be transferred to the PACU where HR, respiratory rate, SpO2 and systolic, diastolic and mean arterial blood pressure were monitored.

Sample size was calculated using G* Power 3.1.7.9 software program. Calculation of the sample size was based on the VAS value measured at different time points. Based on the results of a study by Mostafa et al, the authors calculated the sample size to be able to detect a difference in VAS score of 10 points with an effect size of 0.8. Using the previous data, at least 23 patients in each group were required to detect a significance difference in the postoperative pethidine consumption at α value of 0.05 and study power of 90%. The authors decided to recruit 25 patients in each group to compensate for any possible withdrawals. The sample size calculation was based on a 2-sample independent t-test (2-sided)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I-II undergoing elective posterior cervical spine surgery

Exclusion criteria

  • Patient refusal
  • Patients with any contraindication to regional anesthesia (e.g. local infection, coagulation abnormality)
  • Known allergy to local anesthetics
  • Previous cervical disc surgery or fixation
  • Mental disorders
  • Drug or alcohol abuse.

Treatment and study plan

Bupivacaine Hydrochloride

Drug

10 ml of 0.25% bupivacaine on each side of cervical region at C5

Other names: 0.25% bupivacaine HCL

Lidocaine Hydrochloride

Drug

10ml xylocaine on each side of cervical region at C5

Other names: Xylocaine

Ultrasound

Device

The same anesthesiologist who is experienced in US guided regional anesthesia will perform the block.The five-layered posterior cervical muscles were identified at the level of C5 with a 6-15-MHz linear probe oriented in the transverse plane (SonoSite Edge, Bothell, Washington). The fifth cervical spine was counted from the C7 spinous process with the probe sliding cranially.

needle

Device

the needle (22- G, 50-mm block needle (Visioplex, Vygon) was introduced in-plane through the skin and advanced into the fascial plane between the semispinalis cervicis and semispinalis capitis muscles. After negative aspiration for blood, 20 ml of bupivacaine 0.25% was injected5.

Primary outcomes

  1. postoperative rescue pethidine consumption

    Time frame: 48 hours after operation

    in milligram

Secondary outcomes

  1. Postoperative visual analog pain score (VAS score)

    Time frame: 4 hours postoperatively

    0 to 10 scale as 0: no pain and 10:worst degree of pain

  2. Postoperative visual analog pain score (VAS score)

    Time frame: 8 hours postoperatively

    0 to 10 scale as 0: no pain and 10:worst degree of pain

  3. Postoperative visual analog pain score (VAS score)

    Time frame: 12 hours postoperatively

    0 to 10 scale as 0: no pain and 10:worst degree of pain

  4. Postoperative visual analog pain score (VAS score)

    Time frame: 24 hours postoperatively

    0 to 10 scale as 0: no pain and 10:worst degree of pain

  5. Postoperative visual analog pain score (VAS score)

    Time frame: 48 hours postoperatively

    0 to 10 scale as 0: no pain and 10:worst degree of pain

  6. time to first rescue analgesic request

    Time frame: 1 minute after requiring analgesics

    in milligram

  7. Intraoperative fentanyl consumption

    Time frame: 1 minute after surgery.

    in microgram

  8. Occurrence of postoperative nausea

    Time frame: 2 hours after operation

    yes or no

  9. Occurrence of postoperative vomiting

    Time frame: 2 hours after operation

    yes or no

  10. Occurrence of postoperative pruritis

    Time frame: 2 hours after operation

    yes or no

Other outcomes

  1. Age

    Time frame: 1 hour preoperatively

    in years

  2. body mass index

    Time frame: 1 hour preoperatively

    kg/m2

Sponsors and collaborators

Lead sponsor

Yasser S Mostafa, MD

Other

Registry information

Official study title

Inter-semispinal Plane (ISP) Block for Postoperative Analgesia Following Cervical Spine Surgery: A Prospective Randomized Controlled Trial

Acronym: ISPB

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 22, 2023
Registry last updated
Sep 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.